AhnJBishopJAAkpengBPaiSIBestSR. Xenograft model for therapeutic drug testing in recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol. 2015;124(2);110-115.
2.
AkagiKLiJBroutianTR. Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res. 2014;24(2):185-199.
3.
SeedatRYCombrinckCEBesterPALeeJYBurtFJ. Determination of the complete genome and functional analysis of HPV6 isolate VBD19/10 from a patient with aggressive recurrent respiratory papillomatosis. Epidemiol Infect. 2016;144(10):2128-2135.
4.
YuanHMyersSWangJ. Use of reprogrammed cells to identify therapy for respiratory papillomatosis. N Engl J Med. 2012;367(13):1220-1227.
5.
DiLorenzoTPTamsenAAbramsonALSteinbergBM. Human papillomavirus type 6a DNA in the lung carcinoma of a patient with recurrent laryngeal papillomatosis is characterized by a partial duplication. J Gen Virol. 1992;73(Pt 2):423-428.
